pSBbi_RP_3XNLS-MicroID2-FLAG
(Plasmid
#188523)
-
PurposeEncodes the biotin proximity labeling enzyme MicroID2 with a 3X nuclear localization sequence (NLS) for expression and stable integration into mammalian cells
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 188523 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepSBbi-RP
-
Backbone manufacturerEric Kowarz Lab
- Backbone size w/o insert (bp) 6350
- Total vector size (bp) 7056
-
Vector typeMammalian Expression ; Transposon mediated gene integration
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert name3XNLS-MicroID2
-
SpeciesSynthetic; Aquifex aeolicus
-
Insert Size (bp)652
- Promoter EF1a/RPBSA
-
Tag
/ Fusion Protein
- FLAG (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site SfiI/NcoI (unknown if destroyed)
- 3′ cloning site XbaI (unknown if destroyed)
- 5′ sequencing primer EF1a-F
- 3′ sequencing primer BGH-rev (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pSBbi_RP_3XNLS-MicroID2-FLAG was a gift from James Londino (Addgene plasmid # 188523 ; http://n2t.net/addgene:188523 ; RRID:Addgene_188523) -
For your References section:
MicroID2: A Novel Biotin Ligase Enables Rapid Proximity Dependent Proteomics. Johnson BS, Chafin L, Farkas D, Adair J, Elhance A, Farkas L, Bednash JS, Londino JD. Mol Cell Proteomics. 2022 Jun 7:100256. doi: 10.1016/j.mcpro.2022.100256. 10.1016/j.mcpro.2022.100256 PubMed 35688383